The major drawback to targeting bFGF or PDGF receptors, however, is that these receptors are expressed on cells other than the endothelium, a fact which may increase the potential for adverse side effects.Integrins and angiogenesisEndothelial cells must also be enabled to adhere to the activated tumor stroma to effectively migrate and invade adjacent tissue.